Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Cardiac and bleeding risks across BTK inhibitors
Tam emphasizes atrial fibrillation and bleeding are class risks, but newer BTKis show lower AFib rates than ibrutinib.
Play episode from 35:22
Transcript
